M. Harvey

Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer--a necessary risk?

G. Mead, K. Tung, T. Geldart, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study

M. Glennie, C. Ottensmeier, Anthony P. Williams, 2015, Clinical Cancer Research.

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

V. Goh, T. Powles, M. Highley, 2023, The Lancet. Oncology.

Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study

M. Glennie, C. Ottensmeier, Anthony P. Williams, 2015, Clinical Cancer Research.

Cancer immunotherapy with a chimeric anti-CD40 monoclonal antibody: Evidence of preclinical efficacy.

M. Glennie, P. Johnson, T. Geldart, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.